Form 4: Senseonics Director Steven Edelman Receives Significant Equity Compensation Grant

Senseonics Holdings, Inc. Director Steven Edelman was granted 111,386 restricted stock units and 157,234 stock options as part of the company's non-employee director compensation policy.

Summary

• Steven Edelman, a Director of Senseonics Holdings, Inc. (SENS), received equity compensation on May 23, 2025.
• The grant included 111,386 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock, with a reported price of $0.
• He also received 157,234 stock options with an exercise price of $0.51 per share, expiring on May 22, 2035.
• Both the RSUs and stock options are set to vest in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, contingent on Mr. Edelman's continuous service.
• Following these transactions, Mr. Edelman beneficially owns 1,235,953 shares of common stock and 157,234 stock options directly.

Sentiment

Score: 7

Explanation: The filing reports a routine equity compensation grant to a director, which is a positive for aligning management incentives with shareholder interests and is a standard practice in corporate governance.

Positives

• The grant of restricted stock units and stock options aligns the director's financial interests with long-term shareholder value creation.
• The compensation structure incentivizes continued service and performance from a key board member, fostering stability in corporate governance.

Future Outlook

The granted restricted stock units and stock options are subject to vesting on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, contingent on the director's continuous service.

Industry Context

The grant of equity compensation to non-employee directors is a common practice across publicly traded companies, serving to align director incentives with shareholder interests and retain experienced board members. This filing reflects a routine compensation event within the medical device or healthcare technology sector, where Senseonics operates.

Comparison to Industry Standards

• The structure of granting restricted stock units and stock options with a one-year vesting period or until the next annual meeting is a common compensation practice for non-employee directors in the U.S. public market, particularly in growth-oriented sectors like medical technology.
• While specific values vary by company size and performance, the mechanism aligns with typical corporate governance standards for director remuneration.

Related Party Transactions

• Grant of 111,386 Restricted Stock Units and 157,234 Stock Options to Steven Edelman, a non-employee director, as part of the company's director compensation policy.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• Vesting of 111,386 Restricted Stock Units on the earlier of May 23, 2026, or the next annual stockholders meeting, subject to continuous service.
• Vesting of 157,234 Stock Options on the earlier of May 23, 2026, or the next annual stockholders meeting, subject to continuous service.

Key Dates

Keywords

Senseonics Holdings, SENS, Form 4, Insider Transaction, Equity Compensation, Restricted Stock Units, Stock Options, Director Compensation, Beneficial Ownership